These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4266033)

  • 1. Pathophysiology of schizophrenia and the striatum.
    Klawans HL; Goetz C; Westheimer R
    Dis Nerv Syst; 1972 Nov; 33(11):711-9. PubMed ID: 4266033
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
    Rubovits R; Klawans HL
    Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology and pathophysiology of dopaminergic neurons.
    Hornykiewicz O
    Adv Cytopharmacol; 1971 May; 1():369-77. PubMed ID: 4950404
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinsonism induced by dopaminergic antagonists.
    Hornykiewicz O
    Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine, extrapyramidal system, and psychomotor function.
    Papeschi R
    Psychiatr Neurol Neurochir; 1972; 75(1):13-48. PubMed ID: 4625495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia].
    Bürki HR; Ruch W; Asper H; Baggiolini M; Stille G
    Schweiz Med Wochenschr; 1973 Dec; 103(48):1716-24. PubMed ID: 4753069
    [No Abstract]   [Full Text] [Related]  

  • 9. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
    Fog R
    Acta Neurol Scand Suppl; 1972; 50():3-66. PubMed ID: 4565013
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract]   [Full Text] [Related]  

  • 11. Basal ganglia disorders. An electrophysiologic approach.
    Mercuri NB; Calabresi P; Bernardi G
    Adv Neurol; 1996; 69():117-21. PubMed ID: 8615118
    [No Abstract]   [Full Text] [Related]  

  • 12. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
    Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
    Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of tardive dyskinesias.
    Klawans HL
    Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755
    [No Abstract]   [Full Text] [Related]  

  • 15. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
    Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 17. Corpus striatum in paralysis agitans and in perphenazine-injected rats.
    Pakkenberg H; Bottcher J
    Adv Neurol; 1974; 5():203-9. PubMed ID: 4440571
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basal ganglia disease. Functional neuroanatomy and therapeutic perspectives].
    Ostergaard K; Sunde NA; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5480-3. PubMed ID: 11068522
    [No Abstract]   [Full Text] [Related]  

  • 20. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
    Orzi F; Fornai F; Blandini F
    Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.